Willow Biosciences, Inc. (WLLW) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

90.94 k

Shareholding (Mar 2025)

FII

0.30%

Held by 1 FIIs

DII

99.7%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -61.90%, its profits have risen by 52.5%

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

CAD 6 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.56

Return on Equity

414.80%

Price to Book

-5.79

Revenue and Profits:

Net Sales:

2 Million

(Quarterly Results - Mar 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

33.33%

6 Months

-27.27%

1 Year

-61.9%

2 Years

-66.67%

3 Years

-75.76%

4 Years

-96.19%

5 Years

-92.31%

Willow Biosciences, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

41.44%

EBIT Growth (5y)

9.36%

EBIT to Interest (avg)

-14.71

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.33

Sales to Capital Employed (avg)

1.45

Tax Ratio

0.02%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.30%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.72

EV to EBIT

-0.37

EV to EBITDA

-0.49

EV to Capital Employed

2.06

EV to Sales

0.44

PEG Ratio

Dividend Yield

ROCE (Latest)

-558.10%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.3%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -5.26% vs 11.76% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 66.67% vs 25.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.80",
          "val2": "1.90",
          "chgp": "-5.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.30",
          "val2": "-0.90",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.70%",
          "val2": "-345.90%",
          "chgp": "33.62%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 291.67% vs 50.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 52.31% vs 12.16% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.70",
          "val2": "1.20",
          "chgp": "291.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.20",
          "val2": "-11.60",
          "chgp": "63.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.20",
          "val2": "-13.00",
          "chgp": "52.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,197.10%",
          "val2": "-11,482.90%",
          "chgp": "1,028.58%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

1.80

1.90

-5.26%

Operating Profit (PBDIT) excl Other Income

-0.00

-0.30

100.00%

Interest

0.10

Exceptional Items

0.00

Consolidate Net Profit

-0.30

-0.90

66.67%

Operating Profit Margin (Excl OI)

-9.70%

-345.90%

33.62%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is -5.26% vs 11.76% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 66.67% vs 25.00% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

4.70

1.20

291.67%

Operating Profit (PBDIT) excl Other Income

-4.20

-11.60

63.79%

Interest

0.30

0.10

200.00%

Exceptional Items

0.00

Consolidate Net Profit

-6.20

-13.00

52.31%

Operating Profit Margin (Excl OI)

-1,197.10%

-11,482.90%

1,028.58%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 291.67% vs 50.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 52.31% vs 12.16% in Dec 2023

All Annual Results

Company CV

About Willow Biosciences, Inc.

Willow Biosciences, Inc.

Miscellaneous

Willow Biosciences Inc., formerly Makena Resources Inc., is a Canada-based research and development company. The Company is focused on creating synthetic biology solution from gene discovery to cannabinoid commercialization.

Company Coordinates

Company Details

3655 36th Street NW , CALGARY AB : T2L 1Y8

Tel: 1 403 6694848

https://www.willowbio.com/

Registrar Details